Skip to content
sellWeak10b5-1 plan

Hopkinson Craig C. sold $1.8M of ALKS

EVP R&D, Chief Medical Officer at Alkermes plc.. 58,996 shares at an average of $30.08, traded Nov 11, 2024, filed Nov 12, 2024.

Warning score
15
Value
$1.8M
58,996 shares
Holdings after
83,300
-41% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

The components behind this score (role, size, price context, cluster, track record, modifiers) are shown to Pro users. Start with Pro

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.3%, 3m +9.3%, 6m +5.5%.

Price, last year

ALKS, daily close, last year. insider buy insider sellDot size follows the dollar value (largest $1.8M).

Rows in this filing

Every transaction in Form 4 0001127602-24-027044, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 11, 2024MOption exercise
Ordinary Shares10b5-1
+43,058$20.03$862k142,296Nov 12, 2024
Nov 11, 2024SOpen-market sale
Ordinary Shares10b5-1
-58,996$30.08$1.8M83,300Nov 12, 2024
Nov 11, 2024MOption exercise
Employee Stock Option (Right to Buy)derivative10b5-1
-43,058$0.00$0129,174Nov 12, 2024

Related signals

Other insiders at Alkermes plc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
0Weaksell10b5-1ALKS
Alkermes plc.
Parisi Samuel Joseph
VP, Finance (Interim PAO)
$66k1,938
9Weaksell 210b5-1ALKS
Alkermes plc.
Parisi Samuel Joseph
VP, Finance (Interim PAO)
$132k3,743
0Weaksell 210b5-1ALKS
Alkermes plc.
Parisi Samuel Joseph
VP, Finance (Interim PAO)
$47k1,327
33Weaksell 210b5-1ALKS
Alkermes plc.
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$12M349,340
25Weaksell10b5-1ALKS
Alkermes plc.
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$3.2M100,918
9Weaksell 310b5-1ALKS
Alkermes plc.
LAURENCIN CATO T
director
$86k2,691
40Moderatesell 310b5-1ALKS
Alkermes plc.
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$2.0M61,151
29Weaksell 310b5-1ALKS
Alkermes plc.
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$290k9,221
32Weaksell 310b5-1ALKS
Alkermes plc.
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$442k14,349
21Weaksell 310b5-1ALKS
Alkermes plc.
Nichols Christian Todd
SVP, Chief Commercial Officer
$152k5,208

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Hopkinson Craig C. sold $1.8M of ALKS | InsiderTell